Status:
COMPLETED
Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus
Lead Sponsor:
University Hospital Freiburg
Collaborating Sponsors:
Peschke Meditrade, GmbH
Conditions:
Keratoconus
Eligibility:
All Genders
12+ years
Phase:
PHASE2
PHASE3
Brief Summary
Background: Corneal cross linking is a procedure that induces collagen cross linking of the corneal stroma due to release of reactive oxygen radicals upon activation of topically applied riboflavine A...
Eligibility Criteria
Inclusion
- Only early Keratoconus (Contact lens fitting)
- Progression of Ametropia.
- Corneal thickness \> 450µm
Exclusion
- Further ophthalmic diseases
- History of ocular surgery
- Pregnancy, brest feeding
- Allergy against Riboflavin
- End stage Keratoconus
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00626717
Start Date
August 1 2007
End Date
December 1 2012
Last Update
January 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Eye Hospital Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany, 79106